SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-24-017403
Filing Date
2024-10-03
Accepted
2024-10-03 18:04:06
Documents
2
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 3298
2 POA exhibit24-1.txt EX-24.1 2962
  Complete submission text file 0001062993-24-017403.txt   7782
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Issuer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CENTURY THERAPEUTICS, INC. 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address
Cowan Chad (Reporting) CIK: 0002039294 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40498 | Film No.: 241352890